NAOV Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Stats
Today's Volume	14 826.00
Average Volume	38 266.00
Market Cap	2.25M
EPS	$0 ( 2024-05-20 )
Next earnings date	( $0 ) 2024-08-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.480
ATR14	$0.0100 (1.24%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-23	Mika Thomas	Buy	16 666	Option to Purchase Common Stock
2024-01-23	Jacob Harold	Buy	6 667	Option to Purchase Common Stock
2024-01-23	Schroeder Maria	Buy	16 667	Option to Purchase Common Stock
2024-01-23	Ferguson Michael	Buy	16 666	Option to Purchase Common Stock
2024-01-23	Goldstein Martin M	Buy	16 667	Option to Purchase Common Stock

INSIDER POWER
28.22
Last 97 transactions
Buy: 2 103 083 \| Sell: 846 526

Nanovibronix Inc Correlation

10 Most Positive Correlations
SHLS	0.842
INMD	0.84
CBRL	0.833
RPTX	0.827
NVEE	0.824
SMRT	0.817
AKAM	0.815
SIBN	0.813
GDYN	0.812
OLMA	0.81

10 Most Negative Correlations
SBNY	-0.886
EXC	-0.851
PPC	-0.837
RSVR	-0.827
CGBD	-0.808
FRLA	-0.808
TIGO	-0.805
INO	-0.804
ENTX	-0.804
RZLT	-0.802

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nanovibronix Inc Financials

Annual	2023
Revenue:	$2.28M
Gross Profit:	$1.54M (67.32 %)
EPS:	$-2.12

FY	2023
Revenue:	$2.28M
Gross Profit:	$1.54M (67.32 %)
EPS:	$-2.12

FY	2022
Revenue:	$752 000
Gross Profit:	$167 000 (22.21 %)
EPS:	$-3.84

FY	2021
Revenue:	$1.70M
Gross Profit:	$770 000 (45.43 %)
EPS:	$-0.570

Financial Reports:

No articles found.

Nanovibronix Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Nanovibronix Inc

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.